FINWIRES · TerminalLIVE
FINWIRES

XtalPi Receives Further $19 Million Under Drug Discovery Agreement With DoveTree

By

XtalPi Holdings (HKG:2228) said it received a further $19 million payment from DoveTree Medicines under an AI-driven drug discovery services agreement, according to a Wednesday filing with the Hong Kong bourse.

The bio-tech platform's shares gained over 3% recent trade.

The firm had previously agreed to use its AI and robotics-enabled platform to develop small molecule and antibody drug candidates across multiple therapeutic areas that would then be licensed to DoveTree.

XtalPi received an upfront payment of $51 million at the time and is eligible for milestone payments of up to $5.89 billion and potential royalties on future net sales.

Related Articles

Asia

REF Completes HK$23 Million Share Placement; Shares Gain 3%

REF (HKG:1631) completed the placement of 51.2 million new shares at HK$0.457 apiece, raising net proceeds of about HK$22.7 million, according to a Wednesday Hong Kong bourse filing.Shares of the financial printing services business were up over 3% in Thursday's late morning trade.The company said the shares were placed with at least six independent investors.REF plans to use the proceeds for leasing and renovating a new office in Central, additional staff costs for expanded operations, software and IT-related expenses, and other operating expenses by December 2027.

$HKG:1631
Asia

Hong Kong Court Adjourns Winding-up Hearing Against China Water Industry to June 8

China Water Industry (HKG:1129) said a Hong Kong court adjourned the hearing of a winding-up petition against the company to June 8, according to a Wednesday bourse filing.Shares of the water supply company were down over 2% in late morning trade on Thursday.The petition relates to a May 2022 loan agreement involving New China Water (Nanjing) Renewable Resources Investment, an indirect non-wholly owned subsidiary of the company, and a guarantee provided by China Water Industry.

$HKG:1129
Asia

Shuangdeng Group Completes H-Share Circulation

Shuangdeng Group (HKG:6960) completed its planned H-share circulation in Hong Kong, according to a filing with the city's bourse Wednesday.The battery maker's shares gained nearly 6% in late-morning trade Thursday.The firm converted and listed about 191.8 million domestic shares, or 46% of its total issued capital, into H shares under the full circulation scheme.

$HKG:6960